Metrikler
Yayın
30
Açık Erişim
10
BM Sürdürülebilir Kalkınma Amaçları
Biyografi
2003-2010 Ankara Üniversitesi Tıp Fakültesi
2010-2015 Ankara Üniversitesi Tıp Fakültesi İç Hastalıkları
Eğitim Bilgileri
2019 - Devam Ediyor
2019 - Devam EdiyorTıpta Yandal Uzmanlık
Erciyes Üniversitesi, Tıp Fakültesi, Dahili Tıp Bil., Türkiye
Araştırma Alanları
Sağlık Bilimleri
Akademik Ünvanlar / Görevler
2019 - Devam Ediyor
2019 - Devam EdiyorAraştırma Görevlisi
Erciyes Üniversitesi, Tıp Fakültesi, Dahili Tıp Bil.
2011 - 2015
2011 - 2015Araştırma Görevlisi
Ankara Üniversitesi, Ankara Tıp Fakültesi
Makaleler
Tümü (26)
SCI-E, SSCI, AHCI (12)
SCI-E, SSCI, AHCI, ESCI (26)
ESCI (14)
Scopus (25)
TRDizin (15)
2025
20251. What Does Radiologic Assessment Contribute to Asthma: A Subanalysis of the Turkish Adult Asthma Registry
KIZILIRMAK D., Uzun O., GÖKMEN D., AYDIN Ö., BAŞYİĞİT İ., DURSUN A. B., et al.
Bratislava Medical Journal
, cilt.126, sa.6, ss.1008-1022, 2025 (SCI-Expanded, Scopus)
2025
20252. Mepolizumab: Which condition benefits more: Nasal polyps or eosinophilic asthma? Mepolizumab: Hangi durum daha fazla fayda sağlar: Burun polipleri mi, eozinofilik astım mı?
AÇAR E., KÖYLÜCE S., ŞEKER S., BOZKURT YILMAZ H. E., AKTAŞ YAPICI E., ARSLAN B., et al.
Tuberkuloz ve Toraks
, cilt.73, sa.1, ss.52-59, 2025 (ESCI, Scopus, TRDizin)
2025
20253. Socioeconomic status has direct impact on asthma control: Turkish adult asthma registry
ARSLAN B., TÜRK M., HAYME S., AYDIN Ö., GÖKMEN D., Buhari G. K., et al.
Clinical and Translational Allergy
, cilt.15, sa.1, 2025 (SCI-Expanded, Scopus)
2025
20254. Asthma patients with obesity have a unique phenotype: a subanalysis of the Turkish adult asthma registry
ÇELEBİ SÖZENER Z., OĞUZÜLGEN İ. K., Ozalp Ates F. S., Baccioglu A., ARGUN BARIŞ S., EDİGER D., et al.
Journal of Asthma
, cilt.62, sa.7, ss.1183-1194, 2025 (SCI-Expanded, Scopus)
2024
20245. The definition of remission in asthma should be unique and specific
Yilmaz I., ÇETİN g., Türk M.
Tüberküloz ve Toraks
, cilt.72, sa.2, ss.176-178, 2024 (ESCI, Scopus, TRDizin)
2024
20246. The Effectiveness of Biological Agents on Chronic Rhinosinusitis with Nasal Polyposis in Patients with Comorbid Asthma: A Multicenter Real-Life Study from Türkiye
Demir M., TUNAKAN DALGIÇ C., METE GÖKMEN E. N., SAVAŞ R., EROĞLU S., Ozden G., et al.
MEDICINA-LITHUANIA
, cilt.60, sa.3, 2024 (SCI-Expanded, Scopus)
2024
20247. Characteristics of asthma in an older adult population according to sex and control level: why are asthma symptoms in older women not well-controlled?
KARADOĞAN D., YILMAZEL UÇAR E., YAVUZ Y., BAÇÇIOĞLU A., Oeztuerk A. B., Bozkurt N., et al.
JOURNAL OF ASTHMA
, cilt.61, sa.6, ss.539-549, 2024 (SCI-Expanded, Scopus)
2024
20248. Capsaicin Pretreatment Increases Mast Cell-Mediated But Not Histamine-Induced Wheal and Erythema Responses: A Proof-of-Concept Study
TÜRK M., YILMAZ İ., Bahcecioglu S. N., PAÇACI ÇETİN G., Elieh-Ali-Komi D., Maurer M.
ASTHMA ALLERGY IMMUNOLOGY
, cilt.22, sa.1, ss.49-57, 2024 (ESCI, Scopus, TRDizin)
2024
20249. Doxycycline may be more clinically effective in type 2 chronic rhinosinusitis nasal polyp comorbid with asthma
PAÇACI ÇETİN G., ARSLAN B., YILMAZ İ.
JOURNAL OF ASTHMA
, cilt.61, sa.1, ss.20-26, 2024 (SCI-Expanded, Scopus)
2023
202310. Capsaicin Pretreatment Increases Mast Cell-Mediated But Not Histamine-Induced Wheal and Erythema Responses: A Proof-of-Concept Study
TÜRK M., YILMAZ İ., NAZİK BAHÇECİOĞLU S., PAÇACI ÇETİN G., Elieh-ali-komi D., Maurer M.
ASTHMA ALLERGY IMMUNOLOGY
, 2023 (ESCI)
2023
202311. The Role of Long-Acting Antimuscarinic Agents in the Treatment of Asthma
ARSLAN B., PAÇACI ÇETİN G., YILMAZ İ.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY
, cilt.36, sa.4, ss.189-209, 2023 (SCI-Expanded, Scopus)
2023
202312. Biological therapy management from the initial selection of biologics to switching between biologics in severe asthma
YILMAZ İ., ÇETİN G. P., ARSLAN B., ŞEKER S., YILMAZ H. E. B., AKTAŞ E., et al.
Tüberküloz ve Toraks
, cilt.71, sa.1, ss.75-93, 2023 (ESCI, Scopus, TRDizin)
2023
202313. Biologics for the treatment of severe asthma: Current status report 2023 Ağır astım tedavisinde biyolojikler: Güncel durum raporu 2023
PAÇACI ÇETİN G., Kepil Özdemir S., Can Bostan Ö., Öztop N., Çelebi Sözener Z., KARAKAYA G., et al.
Tuberkuloz ve Toraks
, cilt.71, sa.2, ss.176-187, 2023 (ESCI, Scopus, TRDizin)
2022
202214. Discontinuing Omalizumab Treatment in Super-Responder Patients with Allergic Severe Asthma: Can the Baseline Total IgE Level Be Used as a Biological Marker to Decide Discontinuing Omalizumab Treatment?
ARSLAN B., PAÇACI ÇETİN G., Turk M., GÜLMEZ İ., YILMAZ İ.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
, cilt.183, sa.10, ss.1071-1077, 2022 (SCI-Expanded, Scopus)
2022
202215. Mepolizumab-Related Adverse Events in Severe Eosinophilic Asthma: A Real-Life Study
NAZİK BAHÇECİOĞLU S., TURK M., ATAYIK E., PAÇACI ÇETİN G., ARSLAN B., GÜLMEZ İ., et al.
ASTIM ALLERJI IMMUNOLOJI
, cilt.20, sa.2, ss.81-86, 2022 (ESCI, Scopus, TRDizin)
2022
202216. The Management of Acute and Chronic Urticaria
YILMAZ İ., PAÇACI ÇETİN G., ARSLAN B., Turk M.
ASTIM ALLERJI IMMUNOLOJI
, cilt.20, sa.3, ss.202-204, 2022 (ESCI, Scopus, TRDizin)
2022
202217. Safety Profiles of Biological Therapies Used in Asthma Treatment
PAÇACI ÇETİN G., ARSLAN B., YILMAZ İ.
ASTIM ALLERJI IMMUNOLOJI
, cilt.20, sa.3, ss.127-141, 2022 (ESCI, Scopus, TRDizin)
2022
202218. The adequacy of current diagnostic criteria for making a diagnosis of ABPA
Bahcecioglu S. N., Turk M., PAÇACI ÇETİN G., YILMAZ İ.
TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX
, cilt.70, sa.2, ss.141-148, 2022 (ESCI, Scopus, TRDizin)
2022
202219. Venom immunotherapy and difficulties encountered before and during immunotherapy: Double sensitization, systemic reactions, treatment with omalizumab, and high dose VIT
PAÇACI ÇETİN G., YILMAZ İ., Turk M., ARSLAN B., Bahcecioglu S. N.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.52, sa.4, ss.1223-1234, 2022 (SCI-Expanded, Scopus, TRDizin)
2021
202120. A case of hypersensitivity developing against trace element solution in total parenteral nutrition, proved by skin prick test
PAÇACI ÇETİN G., Turk M., Bahcecioglu S. N., YILMAZ İ.
EUROPEAN JOURNAL OF CLINICAL NUTRITION
, cilt.75, sa.12, ss.1829-1831, 2021 (SCI-Expanded, Scopus)
2021
202121. The Visible and Invisible Faces of the Iceberg of Type 2 Asthma
YILMAZ İ., PAÇACI ÇETİN G.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
, cilt.203, sa.11, ss.1443-1444, 2021 (SCI-Expanded, Scopus)
2021
202122. Asthma phenotype and endotype definitions
YILMAZ İ., PAÇACI ÇETİN G.
TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX
, cilt.69, sa.2, ss.288-290, 2021 (ESCI, Scopus, TRDizin)
2021
202123. Long-term macrolide therapy in asthma
PAÇACI ÇETİN G., Arslan B., YILMAZ İ.
TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX
, cilt.69, sa.4, ss.520-534, 2021 (ESCI, Scopus, TRDizin)
2021
202124. Blood hyperreosinophilia: A diagnostic challenge
PAÇACI ÇETİN G., KÖSE M., ARSLAN B., YILMAZ İ.
TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX
, cilt.69, sa.3, ss.408-415, 2021 (ESCI, Scopus, TRDizin)
2021
202125. Effectiveness of mepolizumab therapy on symptoms, asthma exacerbations, steroid dependence, and small airways in patients with severe eosinophilic asthma
YILMAZ İ., Nazik Bahcecioglu S., Turk M., TUTAR N., PAÇACI ÇETİN G., ARSLAN B.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.51, sa.4, ss.1953-1959, 2021 (SCI-Expanded, Scopus, TRDizin)
2019
201926. Should There be a Washout Period When Switching to Another Biological in Asthma?
PAÇACI ÇETİN G., Yilmaz H. E. B., YILMAZ İ.
ASTIM ALLERJI IMMUNOLOJI
, cilt.17, sa.1, ss.25-27, 2019 (ESCI, Scopus, TRDizin)